Honda A, Salen G, Matsuzaki Y, Batta A K, Xu G, Leitersdorf E, Tint G S, Erickson S K, Tanaka N, Shefer S
Department of Gastroenterology, University of Tsukuba, Tsukuba-city 305-8575, Japan.
J Biol Chem. 2001 Sep 14;276(37):34579-85. doi: 10.1074/jbc.M103025200. Epub 2001 Jul 13.
The accumulation of various 25-hydroxylated C(27)-bile alcohols in blood and their excretion in urine are characteristic features of cerebrotendinous xanthomatosis (CTX) a recessively inherited inborn error of bile acid synthesis caused by mutations in the mitochondrial sterol 27-hydroxylase (CYP27) gene. These bile alcohols may be intermediates in the alternative cholic acid side chain cleavage pathway. The present study was undertaken to identify enzymes and reactions responsible for the formation of these bile alcohols and to explain why Cyp27(-/-) mice do not show CTX-related abnormalities. Microsomal activities of 5beta-cholestane-3alpha,7alpha,12alpha-triol 25- and 26-hydroxylases, 5beta-cholestane-3alpha,7alpha,12alpha,25-tetrol 23R-, 24S-, and 27-hydroxylases and testosterone 6beta-hydroxylase, a marker enzyme for CYP3A, in Cyp27(-/-) mice livers were markedly up-regulated (5.5-, 3.5-, 6.5-, 7.5-, 2.9-, and 5.4-fold, respectively). In contrast, these enzyme activities were not increased in CTX. The activities of 5beta-cholestane-3alpha,7alpha,12alpha-triol 25- and 26-hydroxylases and 5beta-cholestane-3alpha,7alpha,12alpha,25-tetrol 23R-, 24R-, 24S-, and 27-hydroxylases were strongly correlated with the activities of testosterone 6beta-hydroxylase in control human liver microsomes from eight unrelated donors. Troleandomycin, a specific inhibitor of CYP3A, markedly suppressed these microsomal side chain hydroxylations in both mouse and human livers in a dose-dependent manner. In addition, experiments using recombinant overexpressed human CYP3A4 confirmed that these microsomal side chain hydroxylations were catalyzed by a single enzyme, CYP3A4. The results demonstrate that microsomal 25- and 26-hydroxylations of 5beta-cholestane-3alpha,7alpha,12alpha-triol and microsomal 23R-, 24R-, 24S-, and 27-hydroxylations of 5beta-cholestane-3alpha,7alpha,12alpha,25-tetrol are mainly catalyzed by CYP3A in both mice and humans. Unlike Cyp27(-/-) mice, CYP3A activity was not up-regulated despite marked accumulation of 5beta-cholestane-3alpha,7alpha,12alpha-triol in CTX.
各种25-羟基化C(27)-胆汁醇在血液中的蓄积及其经尿液排泄是脑腱黄瘤病(CTX)的特征性表现,CTX是一种由线粒体甾醇27-羟化酶(CYP27)基因突变引起的隐性遗传先天性胆汁酸合成障碍。这些胆汁醇可能是替代胆酸侧链裂解途径中的中间体。本研究旨在鉴定负责这些胆汁醇形成的酶和反应,并解释为什么Cyp27(-/-)小鼠未表现出与CTX相关的异常。Cyp27(-/-)小鼠肝脏中5β-胆甾烷-3α,7α,12α-三醇25-和26-羟化酶、5β-胆甾烷-3α,7α,12α,25-四醇23R-、24S-和27-羟化酶以及睾酮6β-羟化酶(CYP3A的标志物酶)的微粒体活性显著上调(分别为5.5倍、3.5倍、6.5倍、7.5倍、2.9倍和5.4倍)。相比之下,这些酶活性在CTX中并未增加。在来自8名无关供体的对照人肝微粒体中,5β-胆甾烷-3α,7α,12α-三醇25-和26-羟化酶以及5β-胆甾烷-3α,7α,12α,25-四醇23R-、24R-、24S-和27-羟化酶的活性与睾酮6β-羟化酶的活性密切相关。三乙酰竹桃霉素(一种CYP3A的特异性抑制剂)以剂量依赖性方式显著抑制小鼠和人肝脏中的这些微粒体侧链羟化反应。此外,使用重组过表达人CYP3A4进行的实验证实,这些微粒体侧链羟化反应由单一酶CYP3A4催化。结果表明,5β-胆甾烷-3α,7α,12α-三醇的微粒体25-和26-羟化反应以及5β-胆甾烷-3α,7α,12α,25-四醇的微粒体23R-、24R-、24S-和27-羟化反应在小鼠和人中主要由CYP3A催化。与Cyp27(-/-)小鼠不同,尽管CTX中5β-胆甾烷-3α,7α,12α-三醇明显蓄积,但CYP3A活性并未上调。